Debiopharm doses first patient in Phase I trial of cancer combo therapy

Debiopharm has dosed the first patient in a Phase I clinical trial of Debio 0123 combined with carboplatin and etoposide …

Cora highlights data for DNA protecting supplement

Cora Therapeutics has reported positive clinical trial results for efficacy of Halo, an antioxidant supplement, in safeguarding DNA from radiation …

Merck and Eisai tease results for renal carcinoma treatment

Eisai and Merck & Co Inc (MSD) will present data at the American Society of Clinical Oncology (ASCO) meeting from …

Reece Pharmaceuticals onboards outpatient nurses from Ascott for DFI clinical trial

Reece Pharmaceuticals has onboarded outpatient nurses from healthcare provider Ascott, an IQVIA Company, to support its R327 diabetic foot infection …

The future of long Covid trials

Although there continues to be an increase in Covid-19 cases and deaths all around the world, the increase in 2023 …